Chang, Yun Sil <br/><br/>
Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.  [electronic resource] 

 -  The Journal of pediatrics  May 2014 
 - 966-972.e6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1097-6833 
<br/><br/><label>Standard No.: </label>10.1016/j.jpeds.2013.12.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--metabolism<br/>Bronchopulmonary Dysplasia--diagnosis<br/>Cord Blood Stem Cell Transplantation--adverse effects<br/>Cytokines--metabolism<br/>Feasibility Studies<br/>Female<br/>Hepatocyte Growth Factor--metabolism<br/>Humans<br/>Infant, Newborn<br/>Infant, Premature<br/>Logistic Models<br/>Male<br/>Mesenchymal Stem Cell Transplantation--adverse effects<br/>Severity of Illness Index<br/>Trachea--metabolism<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--metabolism